Renascience Inc. (TYO:4889)

Renascience Balance Sheet

Financials in millions JPY. Fiscal year is April - March.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Cash & Equivalents	1,799	2,026	2,212	2,386	1,025
Cash & Short-Term Investments	1,799	2,026	2,212	2,386	1,025
Cash Growth	-11.20%	-8.41%	-7.29%	132.78%	4.59%
Accounts Receivable	-	4	-	-	-
Other Receivables	17	-	-	-	-
Receivables	17	4	-	-	-
Prepaid Expenses	42	29	29	31	7
Other Current Assets	13	27	26	11	10
Total Current Assets	1,871	2,086	2,267	2,428	1,042
Property, Plant & Equipment	-	-	4	3	3
Long-Term Investments	-	2	2	6	7
Other Intangible Assets	-	-	-	-	13
Other Long-Term Assets	-	-	1	1	1
Total Assets	1,871	2,088	2,274	2,438	1,066
Accounts Payable	1	-	-	-	-
Accrued Expenses	1	2	2	2	2
Current Income Taxes Payable	144	123	97	35	26
Other Current Liabilities	5	1	1	-	1
Total Current Liabilities	151	126	100	37	29
Long-Term Debt	-	356	309	199	475
Other Long-Term Liabilities	-	-	-	2	1
Total Liabilities	151	482	409	238	505
Common Stock	1,036	1,036	1,036	1,036	90
Additional Paid-In Capital	1,518	1,518	1,518	1,518	571
Retained Earnings	-835	-948	-690	-354	-100
Comprehensive Income & Other	1	-	1	-	-
Shareholders' Equity	1,720	1,606	1,865	2,200	561
Total Liabilities & Equity	1,871	2,088	2,274	2,438	1,066
Total Debt	-	356	309	199	475
Net Cash (Debt)	1,799	1,670	1,903	2,187	550
Net Cash Growth	7.72%	-12.24%	-12.99%	297.64%	-8.33%
Net Cash Per Share	141.52	131.38	149.70	192.03	56.01
Filing Date Shares Outstanding	12.71	12.71	12.71	12.69	9.82
Total Common Shares Outstanding	12.71	12.71	12.71	12.69	9.82
Working Capital	1,720	1,960	2,167	2,391	1,013
Book Value Per Share	135.31	126.34	146.72	173.40	57.13
Tangible Book Value	1,720	1,606	1,865	2,200	548
Tangible Book Value Per Share	135.31	126.34	146.72	173.40	55.81

Source: S&P Global Market Intelligence. Standard template. Financial Sources.